Silk Road Medical (SILK) shares rallied 24% in the last trading session to close at $26.88. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the stock's 4.7% loss over the past four weeks. For Silk Road Medical, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make ...

NEW YORK, June 18, 2024 /PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Silk Road Medical, Inc. (NASDAQ: SILK) and its board of directors concerning the proposed acquisition of the company by Boston Scientific Corporation (NYSE: BSX). Stockholders will receive $27.50 for each share of Silk Road Medical stock that they hold. The transaction is valued at approximately $1.26 billion and is expected to close in the second half of 2024. If you are a stockholder of Silk Roa ...

Click here to learn how to join the https://www.ademilaw.com/case/silk-road-medical-inc or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you. If you own Silk Road Medical common stock and wish to obtain additional information, please contact Guri Ademi either at [email protected] or toll-free: 866-264-3995, or https://www.ademilaw.com/case/silk-roadmedical-inc. Ademi LLP Guri Ademi Toll Free: (866) 264-3995 Fax: (414) 482-8001 MILWAUKEE, June 18, 2024 /PRNewswire/ -- Ademi LLP ...

Silk Road Medical (NASDAQ:SILK) stock is on the rise Tuesday after the medical device company announced an acquisition deal with Boston Scientific (NYSE:BSX). Now the deal just needs approval from SILK shareholders regulators. If that goes well, the two companies expect the acquisition to close in the second half of 2024. SILK stock is up 24.1% as of Tuesday morning! The stock is also up 120.7% since the start of the year. More Tuesday Stock Market News The acquisition offer from Boston Scientific also has ...

Shareholders of Silk Road Medical are encouraged to contact Johnson Fistel to discuss their legal rights in this matter. You can click or copy and paste the following link to join this investigation: Johnson Fistel, LLP has paid for the dissemination of this promotional communication, and Frank J. Johnson is the attorney responsible for its content. On June 18, 2024, Silk Road Medical informed the public that it has agreed to a deal with Boston Scientific, in which shareholders will receive $27.50 per share ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ______________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38847 ______________________________ SILK ROAD MEDICAL, INC. (Exact name of re ...

Silk Road Medical, Inc (NASDAQ:SILK) Q1 2024 Results Conference Call April 30, 2024 4:30 PM ET Company Participants Marissa Bych - IR Chas McKhann - Chief Executive Officer Lucas Buchanan - CFO and COO Conference Call Participants Rohin Patel - JPMorgan Rick Wise - Stifel Frank Takkinen - Lake Street Capital Markets Suraj Kalia - Oppenheimer Operator Good day, and thank you for standing by. Welcome to Silk Road Medical's 2024 First Quarter Earnings Conference Call. At this time, all participants are in a li ...

Exhibit 99.1 Adjusted EBITDA was a loss of $3.9 million for the first quarter of 2024 compared to a loss of $7.4 million for the first quarter of 2023. For additional information regarding non-GAAP financial measures see "Use of Non-GAAP Financial Measures" and "Reconciliation of GAAP Net Loss to Adjusted EBITDA" below. Cash, cash equivalents and investments were $176.5 million as of March 31, 2024. Silk Road Medical Reports First Quarter 2024 Financial Results SUNNYVALE, Calif., April 30, 2024 (GLOBE NEWSW ...

Silk Road Medical, Inc (NASDAQ:SILK) Q4 2023 Earnings Call Transcript February 28, 2024 4:30 PM ET Marissa Bych - IR, Gilmartin Group IR Chas McKhann - CEO Lucas Buchanan - CFO and COO Rick Wise - Stifel Frank Takkinen - Lake Street Capital Markets Suraj Khalia - Oppenheimer & Co. Kristen Stewart - C.L. King I would now like to hand the conference over to your first speaker today, Marissa Bych, with Gilmartin Group Investor Relations. Please go ahead. Great. Thank you all for joining today's call. Earlier t ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For transition period from to Commission File Number 001-38847 ______________________________ SILK ROAD MEDICAL, INC. (Exact name of registrant as specified in its ...